Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q3 2019 · 10-Q
Revenue$194.00K$194.00K+131.0% vs Q3 2018 Net Income-$3.79M-$3.79MN/M vs Q3 2018 EPS Diluted-$0.63-$0.63N/M vs Q3 2018 Operating Income-$3,227,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,492,000N/M Margins · derivedOperating margin-1663.4%+2586.6 pt vs Q3 2018
Net margin-1954.6%+2264.4 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 19, 2019 · 50 d after period end